Boehringer Ingelheim targets 2% of pharmaceutical market

German pharmaceutical company Boehringer Ingelheim, with a global turnover worth over 10 billion euros, intends to reach a 2% market share in Romania in the coming five years, double against the current share. “Last year, we ranked 28th among players on the local pharmaceutical market, and a doubled market share could enable us to reach the 15th position. In 2007, our Romanian sales advanced by around 31%, one of the fastest growth rates in the group,” said Dan Ionescu, corporate affairs manager of Boehringer Ingelheim Romania. The German manufacturer started its operations on the local market in 1970, and in 1990, a representative office was set up, which employed one person. Currently, Behringer Ingelheim Romania employs 77 people, while sales amount to 22.4 million euros (drugstore prices).